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’INTRODUCTION
The family of ethylene cross-bridged tetraamine macrocyclic
ligands (Figure 1a) has become valuable as metal chelators in
coordination, catalytic, as well as medicinal chemistry.
1,2 Their
pendant-armedderivativeshavebeenespeciallyusefulinendowing
corresponding metal complexes with remarkable kinetic inertness.
One lead bifunctional chelator for copper radiometals has been the
bis-carboxymethyl pendant-armedc r o s s - b r i d g e dc y c l a m ,C B - T E 2 A
(Figure 1b). Its
64Cu-labeled bioconjugates have signiﬁcantly
improved in vivo behavior and superior inertness toward radio-
metal loss and are of interest for positron emission tomography
(PET) imaging applications.
2,3 We have been developing a
second generation of cross-bridged ligands aimed at improving
the kinetics of complexation and decreasing nontarget organ
accumulation.
4 Springborg and co-workers previously reported
an interesting series of trimethylene cross-bridged tetraazama-
crocycles and their coordination chemistry (Figure 1c, 1d).
1,5
A limited number of pendant-armed derivatives of these ligands
have been investigated, though none with ionizable functional
groups.
6,7 We were intrigued whether such a trimethylene cross-
bridged tetraamine derivative would have distinct in vitro or in vivo
behavior compared to its most closely related ethylene cross-bridged
analogues.Wereportherethesynthesisandcharacterizationofadica-
rboxymethyl pendant-armed cyclen with such a cross-bridge, C3B-
DO2A(1),aswellasitsisomericethylenecross-bridgedhomocyclen
ligand, CB-TR2A (2) (Figure 2). Their copper(II) complexes have
beenpreparedandfullycharacterized.Finally,
64Curadiolabelingand
animal biodistribution studies have been carried out for comparison
with each other, and with the widely used chelator CB-TE2A, with
the overall goal of developing the optimal
64Cu-cross-bridged com-
plexforconjugationtobiomoleculesaspotentialPETimagingagents.
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ABSTRACT: Ethylene cross-bridged tetraamine macrocycles are useful
chelators in coordination, catalytic, medicinal, and radiopharmaceutical
chemistry. Springborg and co-workers developed trimethylene cross-
bridgedanalogues,althoughtheirpendant-armedderivativesreceivedlittle
attention. We report here the synthesis of a bis-carboxymethyl pendant-
armed cyclen with a trimethylene cross-bridge (C3B-DO2A) and its
isomeric ethylene-cross-bridged homocyclen ligand (CB-TR2A) as well
as their copper(II) complexes. The in vitro and in vivo properties of these
complexes are compared with respect to their potential application as
64Cu-radiopharmaceuticals in positron emission tomography
(PET imaging). The inertness of Cu-C3B-DO2A to decomplexation is remarkable, exceeding that of Cu-CB-TE2A. Electrochemical
reduction of Cu-CB-TR2A is quasi-reversible, whereas that of Cu-C3B-DO2A is irreversible. The reaction conditions for preparing
64Cu-C3B-DO2A (microwaving at high temperature) are relatively harsh compared to
64Cu-CB-TR2A (basic ethanol). The in vivo
behaviorofthe
64Cucomplexeswasevaluatedinnormalrats.Rapidandcontinualclearanceof
64Cu-CB-TR2Athroughtheblood,liver,
and kidneys suggests relatively good in vivo stability, albeit inferior to
64Cu-CB-TE2A. Although
64Cu-C3B-DO2A clears continually,
theinitialuptakeishighandonlyabouthalfisexcretedwithin22h,suggestingpoorstabilityandtranschelationof
64Cutoproteinsinthe
bloodand/orliver.Thesedatasuggestthatinvitroinertnessofachelatorcomplexmaynotalwaysbeagoodindicatorofinvivostability.3079 dx.doi.org/10.1021/ic200014w |Inorg. Chem. 2011, 50, 3078–3086
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’RESULTS AND DISCUSSION
Synthesis. The ligand C3B-DO2A (1) was synthesized by
N-alkylation of the parent trimethylene cross-bridged Spring-
borg ligand (3, C3B-cyclen)
6 with t-butyl bromoacetate
(Scheme 1) to give diester 4 as a hydrobromide salt. Deprotec-
tion of this product with excess trifluoroacetic acid (TFA)
provided H2-C3B-DO2A, also as a hydrobromide (H2-13HBr).
The synthetic route used for preparation of CB-TR2A (2)i s
shown in Scheme 2. The approach from homocyclen to cross-
bridgedhomocyclenhasbeencommunicatedpreviously,
8butwe
include synthetic details and characterization data herein.
Condensation of homocyclen with aqueous glyoxal in MeCN
leads to a mixture of two constitutionally isomeric cis-fused
tetracyclic bisaminals, 5 (major) and 6 (minor), which were
separated chromatographically.
9 The major isomer (5), the
desired compound, was shown to be cis-fused by virtue of
dynamic NMR spectra indicative of enantiomerization
(selected variable temperature
13C{
1H} NMR spectral data are
includedintheexperimental details forcompound 5).
9,10Highly
regio- and stereoselective dibenzylation of 5 gives rac salt 7
through benzylation on the most sterically available nitrogen
lone pairs. Double reductive ring expansion with NaBH4 gives
dibenzyl cross-bridged homocyclen 8, which is debenzylated to
cross-bridgedhomocyclen9byhydrogenolysis.Inanalogytoour
synthesis of CB-TE2A
3 and C3B-DO2A (1) (vide supra), 9 was
di-N-alkylated with t-butyl bromoacetate to give bis-ester-armed
derivative 10, which was deprotected with TFA to give the
desired ligand as H2-CB-TR2A (H2-2) as a TFA salt.
Therespectivecopper(II)complexesof1and2wereprepared
by reﬂuxing Cu(ClO4)2 overnight with the ligand in a 95%
ethanol solution that was adjusted to pH 8. Isolated crude
complexes were recrystallized from methanol/diethyl ether to
give crystalline products.
Ligand and Complex Spectroscopic Studies. The
1H and
13C{
1H} NMR spectral data for C3B-DO2A (1) and CB-TR2A
(2) are detailed in the Experimental Section. The NMR spectra
of H2-1 exhibit the expected time-averaged 2-fold symmetry in
solution.The
13C{
1H}NMRspectrumexhibits6resonancesand
the
1H NMR spectrum shows the expected singlet for the
enantiotopic hydrogens of the acetate methylenes (N-CH2-
CO2H). On the other hand, H2-2 (TFA salt) is completely
asymmetric as shown by NMR spectroscopy. All of the carbon
resonances are unique and every methylene hydrogen pair is
diastereotopic. The two distinct N-CH2-CO2H resonances ap-
pear as AB and AX multiplets.
Thesolid-stateIRspectraofCu-C3B-DO2A(11)andCu-CB-
TR2A (12) showed carboxylate stretching bands at 1616 and
1609 cm
-1, respectively, both consistent with coordinated
pendant arms. Their d-d electronic spectral maxima in aqueous
solutions are at 614 nm (85 M
-1 cm
-1) and 608 nm (32 M
-1
cm
-1) respectively, also typical of six-coordinate Cu(II) with
N4O2 coordination spheres.
Electrochemical and Acid Inertness Studies. Cyclic voltam-
metry of Cu-C3B-DO2A (11) in 0.1 N sodium acetate revealed
an irreversible reduction wave with a peak potential at -1.05 V
(Ag/AgCl,scanrate200mV/s)withalargecopperstrippingpeak
in the return scan. Under the same conditions, Cu-CB-TR2A
(12)exhibitedaquasi-reversiblereductionwaveat-0.95Vwitha
peak-to-peak separation of 138 mV. Our previous results indi-
cated that Cu(II)-complexes of ethylene cross-bridged cyclam
and its derivatives typically have quasi-reversible reductions while
cyclen analogues display irreversible reductions.
11,12 Thus, elec-
trochemically Cu-C3B-DO2A (11) behaves as expected for a
cross-bridged cyclen complex while the isomeric homocyclen-
based complex Cu-CB-TR2A (12) is more similar to cross-
bridged cyclam complexes. The possible relevance of Cu(II)
reduction potentials to in vivo radio-copper loss from tetraaza-
macrocyclic chelators and their bioconjugates has been
postulated.
12ItwashypothesizedthatCu(II)reductionpotentials
lower than about -0.6 V (Ag/AgCl) may be necessary to avoid
reductionbycommonbioreductants.Ifindeedso,neitherofthese
complexes should be susceptible to in vivo Cu(II) reduction.
Acid inertness data of Cu(II)-tetraamine complexes provide a
convenient measure of their resistance toward demetalation in
aqueous solution. We have found acid inertness half-lives ob-
tained under pseudo ﬁrst-order conditions to be useful ﬁrst
predictors for in vivo viability of
64Cu-labeled chelator
complexes.
2 In particular, Cu-CB-TE2A was shown to have a
half-lifeofmorethan6devenin5MHClat90C.
11Studiesin5
M HCl solutions at 30 C revealed that Cu-C3B-DO2A (11)i s
indeﬁnitely inert while Cu-CB-TR2A (12) dissociated with a
half-life of 10.8(4) h. Remarkably, the Cu-C3B-DO2A (11)
complexonlydemetalatedin12MHClat90Cwithahalf-lifeof
1.1(1) d. To our knowledge, this represents the most acid-inert
copper amine complex studied. Since Springborg reported the
half-lifeoftheparenttrimethylenecross-bridgedcoppercomplex
in5MHClat 25Ctobealmost6days whilewe havefoundthe
isomeric Cu-CB-homocyclen complex to be signiﬁcantly less
inert(half-lifeonly4.8hin1MHCl,30C),
5,13thetrimethylene
bridge does appear to impart greater acid inertness. Here,
Figure 1. (a) Cross-bridged tetraazamacrocycles; (b) CB-TE2A; (c-
d) Trimethylene cross-bridged tetraazamacrocycles.
Figure 2. Isomeric dicarboxymethyl pendant-armed cross-bridged li-
gands 1 and 2.3080 dx.doi.org/10.1021/ic200014w |Inorg. Chem. 2011, 50, 3078–3086
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attachment of the two enveloping carboxymethyl pendant arms
furtherenhancedtheacidinertnessofCu-C3B-DO2A(11)even
beyond that of Cu-CB-TE2A.
X-ray Structural Data. A summary of crystal data for the two
X-ray diffraction studies can be found in Table 1. While the
qualityoftheCu-CB-TR2A(12)crystalusedwasrelativelypoor,
nonetheless three distinct six-coordinated distorted octahedral
complexes with N4O2 coordination spheres were found. Each of
these provides a pendant arm oxygen to bridge two of three
sodium cations which together form a central core for this
assembly.Twoofthese,complexes12Aand12Barewell-defined
(Figure 3). Complex 12A has a [333]/[2233] ligand conforma-
tion while complex 12B adopts instead a [333]/[2323] con-
formation, the distinction mainly being the sign of the N-C-
C-N torsion angle of the short bridge. Complex 12C is
conformationally disordered but possesses the same basic Cu
coordination sphere as 12A and 12B.
Noteworthy are the distinct internal “axial” N-Cu-N angles
of191.3(2)and183.2(2)respectively,witheachcationsunken
into the ligand cavity but with the [333]/[2233] ligand con-
formation engulﬁng the cation more. Corresponding “equatorial”
N-Cu-N angles are similar at 81.3(2) and 80.2(2) respec-
tively. Jahn-Teller elongations in both structures are along
select N-Cu-O axes; N(8)-Cu(2)-O(6) in 12A and
N(3)-Cu(1)-O(2) in 12B. Copper-nitrogen bond distances
in both structures range from 1.96 to 2.24 Å while copper-
oxygen distances are between 1.96 and 2.51 Å (Table 2).
Scheme 2. Synthesis of H2-CB-TR2A (H2-2)
Table 1. Crystal Data for Cu-CB-TR2A (12) and Cu-C3B-
DO2A (11)
a
Cu-CB-TR2A Cu-C3B-DO2A
chemical formula C45H78Cl3Cu3N12Na3O27 C21H30CuF12N4O6
molecular weight 1585.13 726.03
space group P2(1)/c P2(1)/n
color blue blue
a (Å) 20.2068(19) 12.2973(7)
b (Å) 24.613(2) 13.3899(8)
c (Å) 13.0914(12) 17.5444(10)
R (deg) 90.00 90.00
β (deg) 105.8090(10) 106.581(3)
γ (deg) 90.00 90.00
V (Å
3) 6264.6(10) 2768.7(3)
Z 44
Dcacld (g/cm
3) 1.681 1.742
T (K) 173(2) 100(2)
μ (mm
-1) 1.252 (Mo KR) 2.293 (Cu KR)
unique data, Rint 13599 5164
parameters/restraints 804/40 399/0
R1 (I >2 σ(I)) 0.0784 0.0497
R1 (all data) 0.1396 0.0558
wR2 (all data) 0.2026 0.1299
aFor full details, see the Supporting Information.
Scheme 1. Synthesis of H2-C3B-DO2A (H2-1)3081 dx.doi.org/10.1021/ic200014w |Inorg. Chem. 2011, 50, 3078–3086
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The X-ray structure of Cu-C3B-DO2A (11) is shown in
Figure 4. Its good metal-ligand ﬁt is indicated by observed
internal “axial” and “equatorial” N-Cu-N angles of 173.6(1)
and 97.5(1) respectively. Similar numbers were found in a
Cu(II) complex of the parent trimethylene cross-bridged cyclen
(170.5 and 99.0).
5 The ﬁrst angle indicates that the cation is
protruding slightly from the ligand cavity while the latter value is
substantially larger than those found in reported ethylene cross-
bridged ligand Cu(II) complexes (typically around 80)a sa
result of its trimethylene cross-bridging.
14,15 Its Jahn-Teller
elongation is along the N(1)-Cu(1)-O(3) axis which deviates
substantially from linearity at 159. The copper-nitrogen bond
distances range from 2.0 to 2.2 Å, similar to those found in Cu-
CB-TR2A (12), while the Cu-O distances are 2.00 and 2.45 Å.
Inlightoftheseobservations,nosigniﬁcantstructuralinsightcan
be gleaned to account for the very disparate acid inertness
between these two complexes.
Radiochemistry. Consistent with the extremely high acid
inertness of its Cu-complex, radiolabeling of C3B-DO2A was
foundtobeverychallengingandultimatelyrequiredratherharsh
conditions for successful labeling. Radiolabeling was attempted
under a variety of aqueous conditions, varying concentration
(0.5-1μg/μL),buffer(0.1-1.25MNH4OAc,0.1-0.5MNH4-
citrate, and 0.1-0.5 Na2HPO4), pH (4.5-8), and temperature
(25-95 C). Reactions were monitored over time to assess the
rate of complexation. All reactions had very disappointing yields
thatrarelyexceeded50%within2h,evenathightemperature.At
longer time points (3-18 h) the yields were generally better;
however, they rarely were >70%. Furthermore, instability of the
64Cu-C3B-DO2A complex was observed in the form of second-
ary peak formation. Although in our hands, radiolysis has not
been commonly observed for small molecules, reactions were
carried out in the presence of two different radiolytic scavengers
Figure 4. X-ray structure of complex 11 (50% thermal ellipsoids;
hydrogens omitted for clarity).
Figure 3. X-ray structure of12: viewsof complexes 12Aand 12B (50%
thermal ellipsoids; hydrogens omitted for clarity).
Table 2. Selected Bond Data for Cu-CB-TR2A (12) and Cu-C3B-DO2A (11)
a
Cu-CB-TR2A
A B Cu-C3B-DO2A
Cu-N Bond Lengths (Å)
Cu(2)-N(5) 1.975(5) Cu(1)-N(1) 1.968(5) Cu(1)-N(1) 2.201(3)
Cu(2)-N(6) 1.988(5) Cu(1)-N(2) 1.956(6) Cu(1)-N(2) 2.003(3)
Cu(2)-N(7) 2.051(5) Cu(1)-N(3) 2.244(6) Cu(1)-N(3) 2.013(3)
Cu(2)-N(8) 2.228(6) Cu(1)-N(4) 2.041(5) Cu(1)-N(4) 2.002(3)
Cu-O Bond Lengths (Å)
Cu(2)-O(6) 2.513(6) Cu(1)-O(2) 2.501(5) Cu(1)-O(1) 2.003(2)
Cu(2)-O(7) 1.960(4) Cu(1)-O(3) 1.981(4) Cu(1)-O(3) 2.449(2)
N-Cu-N Angles Inside Ligand Cleft (deg)
N(5)-Cu(2)-N(6) 191.3(2) N(1)-Cu(1)-N(2) 183.2(2) N(2)-Cu(1)-N(3) 173.6(1)
N(7)-Cu(2)-N(8) 81.3(2) N(3)-Cu(1)-N(4) 80.2(2) N(1)-Cu(1)-N(4) 97.5(1)
aEstimated standard deviations in parentheses. For full details, see the Supporting Information.3082 dx.doi.org/10.1021/ic200014w |Inorg. Chem. 2011, 50, 3078–3086
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with no significant benefit. Carrier-added reactions did not
improve radiolabeling yields.
After many failed attempts at radiolabeling 1 with high yields
under aqueous conditions, the standard conditions for radiola-
beling CB-TE2A were attempted,
16 by dissolving the compound
(0.5-3 mg) in ethanol (50-100 mL), preincubating it in the
presenceofanexcessofCs2CO3andthenheatingthereactionat
95Cwith100-130μCiof
64Cu.Unfortunately,theyieldswere
still relatively low (30-70% after 1 h) and did not exceed 85%
evenafterseveralhours.ReplacingCs2CO3withLi2CO3resulted
in extremely low yields (3-6%) at all time points (1-18 h).
Again,carrier-addedreactionsdidnotgenerateanyimprovement
in radiolabeling yield.
In an attempt to speed up the reaction kinetics, a microwave
reactor was employed. In all reactions 1.0 μg C3B-DO2A was
incubatedwith∼100μCi
64Cuinatotalvolumeof300μL.Many
diﬀerent reactions were performed where solvent, pH, tempera-
ture, and reaction time were varied, and it was found that the
shortest reaction that consistently provided a greater than 97%
radiochemical purity consisted of microwave heating a solution
of 1 in Milli-Q water at pH = 3 to 100 C for 2 h.
Incontrast,CB-TR2Awassuccessfullylabeledwith
64Cubythe
method employed for CB-TE2A
16 (radiochemical purity g98%)
at room temperature in basic ethanolic solution. A single peak
corresponding to
64Cu-CB-TR2A was conﬁrmed by radio-TLC.
Biodistribution Studies. The biodistribution of
64Cu-C3B-
DO2A and
64Cu-CB-TR2A were determined in normal, juvenile
Lewis rats to examine their in vivo properties. The blood,
liver, and kidney clearance of these agents are plotted in
Figure 5 along with previously published data of
64Cu-CB-
DO2A and
64Cu-CB-TE2A for comparison.
18 Although
64Cu-
CB-TR2Ademonstratedrapidclearancefromthebloodsuggest-
ing that it is stable for the limited time it remains in the
bloodstream, significantly more activity was observed in the
blood at 24 h for
64Cu-CB-TR2A compared to
64Cu-CB-TE2A
(
64Cu-CB-TE2A vs
64Cu-CB-TR2A (%ID/g; p value): 0.003 (
0.0006 vs 0.01 ( 0.002; p = 0.003). Levels of
64Cu-CB-TR2A
remaining in the blood at 24 h were comparable to
64Cu-CB-
DO2A (0.01 ( 0.002 vs 0.011 ( 0.004).
Additionally,moretissueassociatedradioactivitywasobserved
in the kidneys of rats receiving
64Cu-CB-TR2A at 24 h p.i.
compared to the other two CB chelators (
64Cu-CB-TR2A vs
64Cu-CB-TE2A vs
64Cu-CB-DO2A: 0.18 ( 0.05, 0.012 ( 0.003
and 0.064 ( 0.007%ID/g, respectively; p < 0.0001). Similarly,
there was signiﬁcantly greater accumulation in the liver of mice
receiving
64Cu-CB-TR2Acomparedto
64Cu-CB-DO2Aor
64Cu-
CB-TE2A (0.075 ( 0.014, 0.024 ( 0.002, and 0.056 ( 0.012%
ID/g, respectively; p = 0.0003). While the increased
64Cu in the
liver from
64Cu-CB-TR2A may be attributed to hepatobilary
clearance,transchelationofcoppertoliverproteinsisalsoalikely
possibility.
17 Boswell et al. reported the transchelation of radio-
copper to liver proteins such as superoxide dismutase and
metallotheinein after injection of
64Cu labeled CB-chelators.
18
At this time it is unclear why CB-TR2A was less stable in vivo
thanCB-DO2Adespiteitscomparativelylowreductionpotential
anditsrelativekineticacidinertness.
64Cu-C3B-DO2Aexhibited
very slow clearance from the liver compared to CB-TR2A, CB-
DO2A, and CB-TE2A (percent reduction at 22 or 24 h PI: 22.2,
66.4, 69.5 and 90.2% clearance, respectively). Kidney clearance
showedasimilarpattern out to22 or 24 hPI(
64Cu-C3B-DO2A,
50.4%;
64Cu-CB-TR2A, 89.2%;
64Cu-CB-DO2A, 95.6%; and
64Cu-CB-TE2A, 99.1%). The poor bioclearance of
64Cu-C3B-
DO2A compared to the other radiolabeled cross-bridged chela-
tors is surprising. Previously, in vitro assays of Cu(II)-complex
acid inertness and resistance to Cu(II)/Cu(I) reduction have
provided useful indicators of their in vivo stability and bioclear-
ance behavior.
1,12 The very slow hepatic clearance of
64Cu-C3B-
DO2A observed here suggests signiﬁcant radiometal loss in the
liver from what was predicted to be a very inert complex. Close
examination of the X-ray structure of Cu-C3B-DO2A revealed
that the trimethylene cross-bridge led to a larger equatorial N-
Cu-N angle of 98 instead of the 80-88 typical for its
ethylene-bridged analogues but no other noteworthy diﬀerences
in Cu-chelator bonding parameters. The possibility that an
incompletely formed, perhaps out-of-cavity,
64Cu complex being
the actual radiolabeled product can account for the observed
radiocopper loss in vivo. However, the very harsh radiolabeling
conditions(2h,microwave100C,pH3)mitigateagainstsucha
kinetic product. Other contributing factors aﬀecting in vivo
clearance including lipophilicity, susceptibility to metabolic
degradation, or formation of easily reduced ternary complexes
as a consequence of this trimethylene cross-bridge may be
implicated but will require additional SAR studies for
validation.
19
’SUMMARY
The trimethylene cross-bridged chelator C3B-DO2A (1) and
its ethylene cross-bridged isomer CB-TR2A (2) have been
Figure 5. Biodistribution of
64Cu-11 and
64Cu-12 compared to pub-
lished data for
64Cu-CB-DO2A,
64Cu-CB-TE2A.3083 dx.doi.org/10.1021/ic200014w |Inorg. Chem. 2011, 50, 3078–3086
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synthesized and characterized as were their copper(II) com-
plexes. Both complexes have distorted octahedral N4O2 coordi-
nation spheres and should be resistant to biological reduction.
While Cu-CB-TR2A (12) is reasonably resistant to acid decom-
plexation, Cu-C3B-DO2A (11) is remarkably inert. At the same
time, successful radio-copper labeling of CB3B-DO2A (11)
required relatively harsh conditions. Contrary to the highly inert
in vitro behavior of Cu-C3B-DO2A (11), biodistribution studies
of
64Cu-C3B-DO2A revealed very poor in vivo clearance data,
signiﬁcantly inferior to those of
64Cu-CB-TE2A and even
64Cu-
CB-DO2A.
’EXPERIMENTAL SECTION
General Procedures.
1H and
13C{
1H}-NMR spectra were ac-
quired on a Varian Mercury 400 MHz spectrometer operating at 399.75
and 100.51 MHz respectively, on a Varian INOVA 500 MHz spectro-
meter operating at 500 and 125.67 MHz respectively, or on a Bruker
spectrometer operating at 360 and 90.56 MHz respectively or on a
Varian Gemini operating at 300 and 75 MHz respectively. Variable
temperature dynamic
13C{
1H} NMR spectra of 5 were acquired on a
JEOL FX-90Q spectrometer operating at 22.5 MHz. IR spectra were
recorded using KBr pellets on a Nicolet MX-1 FT-IR Spectrophot-
ometer. ESI-MS was performed on a Thermofinnigan LCQ Mass
Spectrometer coupled to a Picoview electrospray source or on a Waters
Micromass ZQ 4000. FAB-MS data were acquired on the JEOL JMS-
AX505HA Mass Spectrometer at the University of Notre Dame.
Electronic spectra were measured using a Cary 219 spectrophotometer.
Elemental analyses were performed at Atlantic Microlab Inc.
Norcross, GA.
All solvents were reagent grade and from commercial sources and
wereused withoutfurtherpuriﬁcation.Allmetal complexationreactions
were performed in standard Schlenk glassware under a nitrogen atmo-
sphere. Recrystallizations were conducted in closed containers without
precautions to exclude either air or moisture. Bulk solvent removal was
byrotaryevaporationunderreducedpressure,andtracesolventremoval
from solids was by vacuum pump evacuation.
Caution! Perchlorate salts of metal complexes containing organic ligands
as solids or in organic solvents are potentially explosive. Although no
problems were encountered by us, cautious handling of only small amounts
of these compounds should be the rule.
Ligand Synthesis. C3B-cyclen (3) was synthesized according to a
procedure previously published by Springborg et al. in 1995.
20 Briefly,
cyclen (1,4,7,10-tetraazacyclododecane) was treated with 2 equiv of p-
toluenesulfonyl chloride (TsCl) in pyridine: the only product obtained
wascyclen-1,7-bis-p-toluenesulfonamide.The3-carboncrossbridgewas
then introduced by alkylation of the 2 secondary nitrogens with 1 equiv
of1,3-propanedioldi-p-toluenesulfonate.TheN-protectingtosylgroups
were removed from the crude product in refluxing HBr/CH3COOH (3
days), and the crude product was recrystallized to give pure 333HBr.
4,10-Bis-(carbo-tert-butoxymethyl)-1,4,7,10-
tetraazabicyclo[5.5.3]pentadecane Hydrobromide (43HBr).
The compound C3B-cyclen33HBr (333HBr, 0.45 g, 0.99 mmol) was
dissolved in MeCN (25 mL). Na2CO3 (0.45 g, 4.2 mmol) and tert-butyl
bromoacetate (0.34 mL, 2.3 mmol) were then added, and the reaction
was heated to 60 C for 3 days. After cooling, solids were removed by
filtration, and the filtrate was evaporated under reduced pressure.
Residual solvent was removed under high vacuum, and the product
was triturated with diethyl ether to give 43HBr (0.42 g) in 81% yield as
the residual solid. This material was taken on without further purifica-
tion.
1H NMR (DMSO-d6, 300 MHz): δ 1.32 (s, 18H, C(CH3)3), 1.68
(m, 2H, NCH2CH2CH2N), 2.65-3.05 (m, 20H, NCH2CH2N and
NCH2CH2CH2N), 3.38 (s, 4H, NCH2C(O)), 12.80 (br s,inside N-H).
13C{
1H} NMR (DMSO-d6, 75 MHz): δ 21.4, 28.5, 50.2, 53.3, 54.1,
55.8, 81.0, 171.4. MS (ESIþ): m/z 441.1 (MH
þ), 385.1 (MH
þ -
1tBu), 329.1 (MH
þ - 2tBu).
4,10-Bis-(carboxymethyl)-1,4,7,10-tetrazazabicyclo-
[5.5.3]pentadecane Hydrobromide (H2-13HBr). The com-
pound 43HBr (0.47 g, 0.90 mmol) was dissolved in a 1:1 mixture of
dichloromethane(DCM,15mL)andtrifluoroaceticacid(TFA,15mL),
and the reaction mixture was stirred at room temperature under argon
for 3 days. DCM and TFA were then evaporated off, the remaining oil
was dissolved in ethanol, and the desired product slowly precipitated
with diethyl ether. After removal of trace solvents under high vacuum,
H2-13HBr (0.34 g) was obtained as a slightly off-white solid in a 92%
yield.
1H NMR (D2O, 300 MHz): δ 1.82 (m, 2H, NCH2CH2CH2N),
2.95-3.25 (m, 20H, NCH2CH2N and NCH2CH2CH2N), 3.61 (s, 4H,
NCH2C(O)).
13C{
1H} NMR (D2O, 75 MHz): δ 18.2, 51.7, 53.8, 53.9,
60.2, 173.1. MS (ESIþ): m/z 329.1 (MH
þ). Elem. analysis: calcd for
C15H28N4O43HBr: C 44.02, H 7.14, N 13.69; found: C 43.94, H 6.92,
N 13.30.
cis-Decahydro-5H-2a,4a,7a,9a-tetraazacyclopenta-
[cd]phenalene (5). Aqueous glyoxal (3.7 mL 40% (w/w); 25.1
mmol) wasadded dropwiseover1hundernitrogentoastirredsolution
of 1,4,7,10-tetraazacyclotridecane (homocyclen) (3.42 g, 18.36 mmol)
in MeCN (100 mL). The reaction mixture was then heated to 60 C for
2.5 h. Solvent was removed under reduced pressure to give a yellow oil,
whichwasdissolvedinCHCl3anddried(Na2SO4).Afterconcentration
of the solution, the crude product was purified by flash chromatography
(basic alumina, 10% EtOH/Et2O) to give the product as a clear oil (Rf
0.29)whichcrystallizeduponstorageat-10C.(1.91g,50%):mp28-
30 C;
1H NMR (360 MHz, CDCl3) δ 1.20-1.32 (dm, 1H, J = 8.1 Hz)
1.90-3.70(brm,19H)2.88(d,J=2.8Hz,CH)3.37(d,J=2.8Hz,CH)
(Note: the
1H NMR spectrum exhibited severe dynamic exchange
broadening.);
13C{
1H} NMR (22.5 MHz, CDCl3, -39 C) δ 19.79
(CH2CH2CH2), (Note: three pairs of peaks (labeled A, B, and C) each
broadened upon warming and coalesced to a singlet by 55 C; see
below) 45.51 and 53.18 (A), 49.35 and 51.82 (B), 51.82 and 54.76 (C),
49.93, 75.39 (CH), 77.74 (CH);
13C{
1H} NMR (22.5 MHz, CDCl3,
55 C) δ 20.35, (Note: the following peaks (labeled A, B, and C)
correspond to three pairs of coalesced resonances.) 49.82 (br) (A),
50.97 (B), 53.83 (C), 50.41, 76.13 (CH), 78.17 (CH); MS, m/z 208
(M
þ);IR(CCl4)2930,2883,2842,2795,2790,1320,1278,1161,1130,
1112, 1095 cm
-1. Anal. Calcd for C11H20N4: C, 63.43; H, 9.68; N,
26.90. Found: C, 63.17; H, 9.98; N, 27.02. A minor component (0.20 g,
5%), was also isolated during the flash chromatography (Rf 0.07):
1H
NMR (360 MHz, CDCl3) δ 1.40 (dtt, 1H, J = 15.0, 5.6, 2.0 Hz) 2.02
(dtt, 1H, J =15.0, 10.7, 2.9 Hz) 2.45-2.85 (m, 8H) 2.92-3.08 (m, 3H)
3.13 (ddd, 2H, J = 13.7, 5.7, 2.6 Hz) 3.27-3.40 (m, 2H) 3.59 (s, 2H,
CHCH);
13C NMR (90.56 MHz, CDCl3) δ 25.11, 49.33, 51.31, 51.63,
52.31, 80.94. These spectra are consistent with the constitutionally
isomeric cis-fused tetracyclic bisaminal 6.
(9br,9cr)-Decahydro-2a,7a-bis(phenylmethyl)-5H-
4a,9a-diaza-2a,7a-diazoniacyclopenta[cd]phenalene Di-
bromide (7). To a stirred solution of purified homocyclen-glyoxal
adduct 5 (1.49 g, 7.17 mmol) in MeCN (35 mL) at room temperature
was added benzyl bromide (12.40 g, 72.50 mmol), all in one portion.
The reaction mixture was stirrred at room temperature for 3 weeks.
Precipitate was collected by suction filtration, washed with MeCN (2  
30mL),thenCH2Cl2(3 15mL).Residualsolventwasremovedunder
vacuum. This gave product as white solid (3.60 g, 90%): mp 222-
225 C (dec);
1H NMR (360 MHz, D2O, MeCN secondary ref set at
2.06ppm)δ1.86-1.97(dm,1H,J=15.0Hz,H6-eq)2.15-2.33(m,1H,
H6-ax) 2.78 (td, 1H, J = 12.2, 2.9 Hz) 3.09-3.92 (m, 13H) 4.21-4.39
(m,2H),4.78and5.09(AB,2H,J=13.3Hz,CH2Ph)4.87and5.18(AB,
2H, J = 13.0 Hz, CH2Ph), 4.95 and 5.12 (AB, 2H, J = 1.1 Hz, CHCH),
7.30-7.90 (m, 10H, Ph);
13C{
1H} NMR (90.56 MHz, D2O, MeCN
secondary ref set at 1.70 ppm) δ 19.40 (CH2CH2CH2), 43.37, 46.34,3084 dx.doi.org/10.1021/ic200014w |Inorg. Chem. 2011, 50, 3078–3086
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47.68, 48.94, 51.25, 52.84, 61.05, 61.16, 61.37, 63.34, 76.81 (CH), 78.82
(CH), 125.56 (1C), 126.62 (1C), 130.28 (2C), 130.52 (2C), 132.18
(2C), 133.18 (2C), 134.10 (2C); IR (KBr) 3062, 3050, 3026, 3018,
2996,2957,2915,2886,2864,2844,2821,2807,1480,1456,1437,1283,
1212, 1146, 1110, 1055, 769, 711, 706 cm
-1. Anal. Calcd for
C25H34N4Br230.5H2O: C, 53.68; H, 6.31; N, 10.02. Found: C, 53.94;
H, 6.10; N, 9.97.
4,11-Bis(phenylmethyl)-1,4,8,11-tetraazabicyclo-
[6.5.2]pentadecane (8). NaBH4 (13.10 g, 0.340 mol) was added in
small portions over 20 min to a stirred solution of dibenzyl tetracyclic
bisaminal dibromide salt 7 (3.05 g, 5.55 mmol) in 95% EtOH (75 mL).
Thereactionmixturewasstirredatroomtemperaturefor10days.Excess
NaBH4 was then decomposed by slow addition of 150 mL 3 M HCl.
Evaporation of solvent under reduced pressure gave a white solid which
was dissolved in H2O (100 mL), adjusted to pH 14 with solid KOH
(withcooling),andextractedwithbenzene(6 50mL).Thecombined
extracts were dried (Na2SO4), and solvent was removed under reduced
pressure to yield 1.44 g (quant) of product as a viscous oil;
1H NMR
(360MHz,C6D6)δ1.37-1.60(m, 2H,CH2CH2CH2),2.26-2.49(m,
5H), 2.53-2.73 (m, 7H), 2.78 (ddd, 1H, J = 13.7, 4.3, 2.6 Hz), 2.82-
3.04 (m, 5H), 3.09-3.21 (m, 1H), 3.26 and 3.64 (AB, 2H, J = 13.4 Hz,
CH2Ph),3.60and3.62(AB,2H,J=14.4Hz,CH2Ph),3.88(ddd,1H,J=
12.7, 8.2, 4.9 Hz), 7.07-7.41 (m, 10H, CH2Ph);
13C{
1H} NMR (90.56
MHz, C6D6) δ 28.59 (CH2CH2CH2), 52.39, 53.78, 55.43, 55.84, 56.36,
56.43, 57.04, 57.93, 59.04, 59.48, 60.82, 60.99, 126.93, 126.98, 128.41,
128.42, 129.08, 129.39, 140.92, 141.03; MS, m/z 392 (M
þ); IR (neat)
3077,3053,3020,2919,2863,2800,2784,2745,2721,2702,1448,1364,
1110,1046,1025,729,696cm
-1;HRMSexactmasscalcdforC25H37N4
393.3018, found 393.3012. The
13C and
1H NMR spectra showed the
material to be >98% purity.
1,4,8,11-Tetraazabicyclo[6.5.2]pentadecane (9). Hydroge-
nolysis of 8 was carried out in a glass apparatus designed for the
exclusion of O2 and for measurement of H2 uptake with maintenance
of constant pressure. 10% Pd/C (0.20 g) and glacial HOAc (60 mL)
wereaddedtoa125mLhydrogenationflaskwhichwasconnectedtothe
apparatus. The systemwas evacuated (water aspirator) andflushed with
nitrogen four times. The system was then evacuated, filled with hydro-
gen, and catalyst was equilibrated under H2 (767 mmHg) for 1.5 h. To
this was added a solution of 8 (1.11 g, 2.83 mmol) in glacial HOAc
(5 mL). The mixture was stirred for 19 h under H2 (767 mmHg). (The
theoreticalH2uptakeforthisreactionwas138mL.Theobserveduptake
was 144 mL.) The apparatus was then evacuated and flushed with
nitrogen four times, the reaction flask was removed from the apparatus,
the contents were filtered through Celite, and the catalyst and Celite
were washed with glacial HOAc (2   5 mL). The combined filtrate and
washings were concentrated under reduced pressure to give a light
yellow oil which was dissolved in H2O (50 mL), adjusted to pH 14 with
KOH, and extracted with benzene (5 50 mL). Thecombinedextracts
were dried(Na2SO4),and solventwas removed underreduced pressure
to give an oil. After kugelrohr distillation (90-120 C air bath
temperature, 0.03 mmHg), the product oil solidified upon standing to
give 0.494 g (82% crude yield) of solid product. This material contained
minor impurities and was therefore further purified. The solid was
dissolved in absolute EtOH (5 mL) containing conc HCl (1 mL). A
hydrochloride salt crystallized, was filtered, washed with cold (0-5 C)
absolute EtOH (2   1 mL), and air-dried. This solid was dissolved in
H2O (10 mL), adjusted to pH 14 with solid KOH (with cooling), and
extracted with benzene(6 15 mL).Thecombinedextractswere dried
(Na2SO4), and solvent was removed under reduced pressure to give an
oil. This oil was kugelrohr distilled (100 C air bath temperature, 0.03
mmHg) and subsequently solidified upon standing to give 0.283 g
(47%) of pure product as a white solid: mp 28-30 C;
1H NMR (360
MHz,C6D6)δ1.26-1.51(m,2HCH2CH2CH2),2.10-2.90(m,21H),
3.30 (ddd, 1H, J = 12.1, 7.5, 2.4 Hz);
13C{
1H} NMR (90.56 MHz,
C6D6) δ 27.14 (CH2CH2CH2), 47.68, 48.56, 48.89, 49.02, 52.85, 53.27,
53.59, 54.20, 55.97, 59.41; MS, m/z 212 (M
þ); IR (KBr) 3474, 2948,
2929, 2907, 2894, 2845, 2699, 1577, 1464, 1399, 1356, 1342, 812, 612,
523 cm
-1; HRMS exact mass calcd for C11H25N4 213.2079, found
213.2078.
4,11-Bis-(carbo-tert-butoxymethyl)-1,4,8,11-
tetraazabicyclo[6.5.2]pentadecane (10). To a stirred solution of
9(35.0mg,0.165mmol)inMeCN(8mL),sodiumcarbonate(50.0mg,
0.472 mmol) was added in one portion, followed by tert-butyl bromoa-
cetate (0.050 mL, 0.34 mmol) via syringe. The mixture was stirred for 3
daysatroomtemperature.Solventwasremovedunderreducedpressure
to yield crude product, which was subjected to flash chromatography
(SiO2,C H 2Cl2:MeOH = 10:1) to yield product as light yellow oil (40.0
mg, 0.0909 mmol, 55%):
1H NMR (500 MHz, C6D6) δ 1.30-1.46 (m,
2H), 1.40 (s, 18H), 2.25 (dt, 1H, J = 13.9, 2.9 Hz), 2.50-2.62 (m, 5H),
2.72-2.88(m,10H),2.88-2.95(m,1H),2.96-3.03(m,1H),3.09and
3.17 (AB, 2H, J = 16.4 Hz), 3.20 (br s, 2H), 3.24-3.31 (m, 1H), 3.59
(ddd, 1H, J = 12.5, 9.8, 4.9 Hz);
13C{
1H} NMR (125.7 MHz, C6D6) δ
28.36, 28.60, 28.61, 51.24, 53.34, 55.08, 55.82, 56.86, 57.39, 57.52 (2C),
57.66, 57.74, 59.84, 60.22, 80.17, 80.22, 171.52, 172.08; IR(neat) 2976,
2924,2852,2800,1734,1719,1457,1367,1152,1124;HRFABMS,m/z
(M þ H)
þ exact mass for C23H45N4O4: 441.3441; Found: 441.3456
(error þ1.5 mmu/þ0.3 ppm)
4,11-Bis-(carboxymethyl)-1,4,8,11-tetraazabicyclo-
[6.5.2]pentadecane (H2-233.7TFA). A solution of 10 (96.0 mg,
0.218 mmol) in trifluoroacetic acid (3.4 mL, 0.046 mol) and CH2Cl2
(3.4mL)wasstirredunderN2for2days.Thereactionmixturewasthen
concentratedunderaspiratorpressureandresidualsolventwasremoved
under vacuum to give 0.1635 g (0.2179 mmol, quant) of H2-CB-TR2A
(H2-2) asabrownoilwith3.7equivofTFAbymass.
1HNMR(MeCN-d3,
500 MHz) δ 1.69-1.76 (dm, 1H, J = 16.8 Hz), 2.14-2.28 (m, 1H),
2.82-3.52 (m, 22-23H), 3.53 and 3.89 (AX, 2H, J = 17.6 Hz,
NCH2CO2), 3.86 and 4.05 (AB, 2H, J = 17.4 Hz, NCH2CO2), 11.64
(br s, 6H, includes all COOH peaks);
13C{
1H} NMR (MeCN-d4,
125.68 MHz) δ 20.94, 48.58, 50.04, 50.40, 52.25, 53.36 (br), 53.85,
55.16 (br),55.69, 56.37, 57.59,58.21, 58.40,117.08 (q,
1JCF=283.2 Hz,
F3CCOOH), 160.67 (q,
2JCF = 37.0 Hz, F3CCOOH), 170.88, 172.99.
(
1H NMR integration from 2.82 to 3.52 ppm was slightly high, likely
because of H2O). This material was complexed with Cu(ClO4)236H2O
without further purification (vide infra).
Complex Synthesis. Cu-C3B-DO2A (11). An amount of 100 mg
(0.203 mmol) of the C3B-DO2A (1) as a trifluoroacetate salt was
combined with 75 mg (0.203 mmol) of Cu(ClO4)236H2O in 8 mL of
95% ethanol. The pH was adjusted to 8.5 with 0.1 N NaOH. This
suspension was refluxed under nitrogen for 24 h to give a dark blue
solution. After thorough removal of volatiles under reduced pressure, a
dark-blue sticky solid was obtained. This was extracted with 4 mL of
methanol and centrifuged. The supernatant was then placed in vials
insideaglasscontainerfordiethyletherdiffusion.Atotalcropof75mgof
dendriticdark-bluecrystalsformed(64%yield).Elem.analysis:calcdfor
C15CuH26N4O431.33NaClO431.33H2O: C 31.24, H 5.01, N 9.71, Cl
8.18%. Found: C 31.05, H 5.21, N 9.45, Cl 8.06%. Electronic spectrum
(aq.) λmax 614 nm (ε = 84.6 M
-1 cm
-1). FT-IR (KBr) νCOO 1687,
1616 cm
-1. X-ray crystals were grown from a hexafluoro-i-propanol
solution upon diethylether diffusion.
Cu-CB-TR2A (12). To a solution of 233.7 TFA (0.1635 g, 0.2179
mmol) in 95% EtOH (15 mL) was added Cu(ClO4)236H2O (136 mg,
0.366 mmol), and the pH of the reaction mixture was adjusted to 8 with
1 M NaOH. The reaction was then refluxedunder N2forapproximately
23 h. The reaction mixture was centrifuged, and the supernatant
collected and concentrated under aspirator pressure. Residual solvent
wasremovedundervacuumtogive264mgofabluesolid.Thissolidwas
dissolved in 95% EtOH (15 mL), and the blue solution was placed in a
diethyl ether diffusion chamber. A powdery blue solid was collected to3085 dx.doi.org/10.1021/ic200014w |Inorg. Chem. 2011, 50, 3078–3086
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give 55.3 mg (44% yield) of purified product. Elem. analysis: calcd for
Cu(C15H26N4O4)3 2H2O31.2NaClO4: C, 31.45; H, 5.28; N, 9.78; Cl,
7.43. Found C, 31.49; H, 5.14, N, 9.68, Cl, 7.10; IR (KBr) 3536, 3490,
3430, 3394, 3364, 1610, 1485, 1437, 1397, 1320, 1098, 631 cm
-1.U V -
vis (H2O) λmax 608 (ε = 32.1 M
-1 cm
-1); Cyclic voltammetry
conducted in 0.1 sodium acetate: indicated a quasi-reversible reduction
with EF = -0.950 V (Ag/AgCl). A 0.13 M solution of Cu-CB-TR2A32
(H2O)31.2(NaClO4) in 95% EtOH was placed in a diethylether
diffusion chamber. Plate-like blue crystals were collected for X-ray
structural analysis, which yielded an empirical formula of Cu-CB-
TR2A3H2O3NaClO4.
X-ray Crystallography. Cu-CB-TR2A (11). A blue plate crystal
was mounted in a Nylon loop, and X-ray diffraction data collected on a
Bruker D8 diffractometer equipped with an APEX CCD detector at
173 K. The monoclinic space group P21/c was uniquely assigned from
systematicabsences.Thestructurewassolvedbydirectmethods.Except
as noted, non-hydrogen atoms were refined with anisotropic thermal
parameters, and hydrogen atoms were included as idealized contribu-
tions. The structure was found to be extensively disordered with regard
to both the macrocycle and the counterions. Satisfactory disorder
models could be created for both, but extensive restraint was necessary
becauseoflimitedresolutioninthediffractiondata.Theperchlorateions
were refined as rigid tetrahedra, and several carbon atoms in the
heterocycle were refined with isotropic thermal parameters. Addition-
ally, the thermalparameters forC37 and itsdisorder partner, C37awere
refined with the EADP command.
Cu-C3B-DO2A (12). A blue rod 0.15   0.10   0.10 mm in size was
mounted on a Cryoloop with Paratone oil. Data were collected in a
nitrogen gas stream at 100(2) K using j and ω scans. Crystal-to-
detectordistancewas60mmandexposuretimewas10sperframeusing
a scan width of 0.5. Data collection was 99.9% complete to 67.00 in q.
A total of 26635 reflections were collected covering the indices, -14 e
h e 14, -16 e k e 16, -21 e l e 16. A total of 5166 reflections were
foundtobesymmetryindependent,withanRintof0.0299.Indexingand
unit cell refinement indicated a primitive, monoclinic lattice. The space
groupwasfoundtobeP2(1)/n(No.14).Thedatawereintegratedusing
the Bruker SAINT software program and scaled using the SADABS
software program. Solution by direct methods (SIR-97) produced a
complete heavy-atom phasing model consistent with the proposed
structure. All non-hydrogen atoms were refined anisotropically by full-
matrix least-squares (SHELXL-97). All hydrogen atoms were placed
using a riding model. Their positions were constrained relative to their
parent atom using the appropriate HFIX command in SHELXL-97.
Radiochemistry. The highest radiochemical purity with greatest
consistency ofyield was obtained usingamicrowave assistedreaction. A
solution of
64CuCl2 (750 μCi in 50 μL Milli-Q water, pH 3) was added
to4.61μg(14.0nmol)C3B-DO2Adissolvedin250μLofMilli-Qwater
(pH3).Thesealedvialcontainingthereactionmixturewasplacedinthe
microwave reactor, stirred for 2 min, and then heated at 100 C for 2 h.
Complex formation was confirmed by radio-TLC (Rf ∼ 0.8, C18 silica
plates,eluent:methanol/10%ammoniumacetate7:3,Rf(
64Cu-acetate=0).
Radiochemical purity was determined by HPLC and found to be g98%
beforeuseinanimalstudies(Complexretentiontime10.55min;Agilent
C8 column; isocratic, 0.1% TFA in water; 0.5 mL/min).
Biodistribution Studies. Animal experiments were carried out in
compliance with the Guidelines for the Care and Use of Research
Animals established by Washington University’s Animal Studies Com-
mittee. Tissue distribution studies were performed in male Lewis rats
(34-42 day old) after intravenous injection of the radiolabeled com-
pound,
64Cu-C3B-DO2A (45 μCi; 0.9 nmol ligand) and
64Cu-CB-
TR2A (100 μCi) via the tail vein (100-150 μL). Tissue biodistribution
data were obtained at 1, 4, and 24 h post injection (PI). Animals were
sacrificed at the appropriate time points, organs of interest were
removed and weighed, and the radioactivity was measured in a gamma
counter. The percent injected dose per gram (%ID/g) and percent
injected dose per organ (%ID/organ) were calculated by comparison to
a weighed and counted standard. Rats were allowed food and water ad
libitum. Animals in the 24 h group for
64Cu-C3B-DO2A and
64Cu-
NOTA were maintained in metabolism cages; urine and feces were
collected.
All biodistribution data are presented as the mean ( standard
deviation. Group comparisons were made using standard ANOVA
methods. Post hoc testing of individual group diﬀerences was accom-
plished with the Bonferroni test. Groups with p < 0.05 were considered
signiﬁcantly diﬀerent. GraphPad Prism software (version 5.02; San
Diego, CA) was used for all statistical analyses.
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